Angiotensin II as a First-line Vasopressor for Distributive Shock During or After Heart Transplantation or Durable Left Ventricular Assist Device Implantation: A Pilot Study
Latest Information Update: 06 Oct 2022
At a glance
- Drugs Angiotensin II (Primary)
- Indications Hypotension; Postoperative complications
- Focus Therapeutic Use
- 30 Sep 2022 Status changed from not yet recruiting to recruiting.
- 13 Feb 2022 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 13 Feb 2022 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.